Back to School: How biopharma can reboot drug development. Access exclusive analysis here

OXi-4503 combretastatin A1 di-phosphate: Interim Phase I data

Interim data from 19 patients in a U.K. Phase I

Read the full 107 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE